Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Editorial: Forging new frontiers in HIV and aging

Editorial: Forging new frontiers in HIV and aging Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/02/2020 EDITORIAL URRENT Forging new frontiers in HIV and aging PINION a b Mary C. Masters and Kristine M. Erlandson As readers of this journal know well, antiretroviral future interventions. Hunt and Payne (pp. 101–109) therapy (ART) has transformed HIV from a terminal provide insight into measurement of mitochondrial disease to a now manageable, chronic condition. function, and examine the contribution of mito- Effective ART extends life expectancy of persons chondrial dysfunction to adverse aging in PWH, with HIV (PWH) near that of the general population. including the impact of prior ART. As the number of PWH with multimorbidity As a result, the number of older PWH continues to rise. The Centers for Disease Control estimates that grows, HIV clinical research must move beyond a nearly 50% of PWH in the United States are aged focus on isolated comorbidities. De Francesco, 50 years or more. This ‘graying’ of the HIV epidemic Sabin, and Reiss (pp. 110–117) discuss analytic appro- will continue: models from some European coun- aches to assessment of multimorbidity patterns in tries estimate that those aged 50 years or older will PWH. Improved understanding of these patterns account for more than http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV & AIDS Wolters Kluwer Health

Editorial: Forging new frontiers in HIV and aging

Loading next page...
 
/lp/wolters-kluwer-health/editorial-forging-new-frontiers-in-hiv-and-aging-JCDmOSY9K1

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0000000000000610
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/co-hivandaids by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/02/2020 EDITORIAL URRENT Forging new frontiers in HIV and aging PINION a b Mary C. Masters and Kristine M. Erlandson As readers of this journal know well, antiretroviral future interventions. Hunt and Payne (pp. 101–109) therapy (ART) has transformed HIV from a terminal provide insight into measurement of mitochondrial disease to a now manageable, chronic condition. function, and examine the contribution of mito- Effective ART extends life expectancy of persons chondrial dysfunction to adverse aging in PWH, with HIV (PWH) near that of the general population. including the impact of prior ART. As the number of PWH with multimorbidity As a result, the number of older PWH continues to rise. The Centers for Disease Control estimates that grows, HIV clinical research must move beyond a nearly 50% of PWH in the United States are aged focus on isolated comorbidities. De Francesco, 50 years or more. This ‘graying’ of the HIV epidemic Sabin, and Reiss (pp. 110–117) discuss analytic appro- will continue: models from some European coun- aches to assessment of multimorbidity patterns in tries estimate that those aged 50 years or older will PWH. Improved understanding of these patterns account for more than

Journal

Current Opinion in HIV & AIDSWolters Kluwer Health

Published: Mar 1, 2020

There are no references for this article.